Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuke Suzuki

Showing results (661-670 of 752) with videos related to

Pageof 76
Sort By:
Electromagnetic Biology and Medicine|January 22, 2019
Acute effects of capacitive and resistive electric transfer (CRet) on the Achilles tendonTsubasa Bito, Yuto Tashiro, Yusuke Suzuki, et al.
Frontiers in Medicine|July 29, 2021
Association Between Kidney Function Decline and Baseline TNFR Levels or Change Ratio in TNFR by Febuxostat Chiefly in Non-diabetic CKD Patients With Asymptomatic HyperuricemiaTomohito Gohda, Naotake Yanagisawa, Maki Murakoshi, et al.
JAMA Internal Medicine|April 14, 2019
Evaluating a New International Risk-Prediction Tool in IgA NephropathySean J Barbour, Rosanna Coppo, Hong Zhang, et al.
Journal of Nephrology|March 2, 2011
One-year results of an open-label study on antiproteinuric effect of benidipine in elderly patients with chronic kidney diseaseYasuhiko Tomino, Yoshio Shimizu, Chieko Hamada, et al.
Kidney International|April 28, 2019
A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathyJames R Myette, Toshiki Kano, Hitoshi Suzuki, et al.
Neuroimage|January 19, 2016
The inhibition/excitation ratio related to task-induced oscillatory modulations during a working memory task: A multtimodal-imaging study using MEG and MRSYuichi Takei, Kazuyuki Fujihara, Minami Tagawa, et al.
International Journal of Clinical Oncology|April 28, 2024
The real-world data of immune-checkpoint inhibitor combination therapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort studySho Sato, Takashi Ssuzuki, Takashi Chinen, et al.
BMC Gastroenterology|September 2, 2024
Evaluation of pembrolizumab plus cisplatin and fluorouracil in radical treatment for patients with T4b esophageal squamous cell carcinomaNobukazu Hokamura, Takeo Fukagawa, Ryoji Fukushima, et al.
Journal of Gastroenterology|August 17, 2024
Prognostic factors of second-line nivolumab monotherapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study for 184 casesSho Sato, Takashi Suzuki, Takashi Chinen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 3, 2020
IgA Nephropathy Benefits from Compound K Treatment by Inhibiting NF-κB/NLRP3 Inflammasome and Enhancing Autophagy and SIRT1Chung-Yao Wu, Kuo-Feng Hua, Wan-Han Hsu, et al.
Pageof 76

Showing results (661-670 of 752) with videos related to

Sort By:
Pageof 76
Electromagnetic Biology and Medicine|January 22, 2019
Acute effects of capacitive and resistive electric transfer (CRet) on the Achilles tendonTsubasa Bito, Yuto Tashiro, Yusuke Suzuki, et al.
Frontiers in Medicine|July 29, 2021
Association Between Kidney Function Decline and Baseline TNFR Levels or Change Ratio in TNFR by Febuxostat Chiefly in Non-diabetic CKD Patients With Asymptomatic HyperuricemiaTomohito Gohda, Naotake Yanagisawa, Maki Murakoshi, et al.
JAMA Internal Medicine|April 14, 2019
Evaluating a New International Risk-Prediction Tool in IgA NephropathySean J Barbour, Rosanna Coppo, Hong Zhang, et al.
Journal of Nephrology|March 2, 2011
One-year results of an open-label study on antiproteinuric effect of benidipine in elderly patients with chronic kidney diseaseYasuhiko Tomino, Yoshio Shimizu, Chieko Hamada, et al.
Kidney International|April 28, 2019
A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathyJames R Myette, Toshiki Kano, Hitoshi Suzuki, et al.
Neuroimage|January 19, 2016
The inhibition/excitation ratio related to task-induced oscillatory modulations during a working memory task: A multtimodal-imaging study using MEG and MRSYuichi Takei, Kazuyuki Fujihara, Minami Tagawa, et al.
International Journal of Clinical Oncology|April 28, 2024
The real-world data of immune-checkpoint inhibitor combination therapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort studySho Sato, Takashi Ssuzuki, Takashi Chinen, et al.
BMC Gastroenterology|September 2, 2024
Evaluation of pembrolizumab plus cisplatin and fluorouracil in radical treatment for patients with T4b esophageal squamous cell carcinomaNobukazu Hokamura, Takeo Fukagawa, Ryoji Fukushima, et al.
Journal of Gastroenterology|August 17, 2024
Prognostic factors of second-line nivolumab monotherapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study for 184 casesSho Sato, Takashi Suzuki, Takashi Chinen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 3, 2020
IgA Nephropathy Benefits from Compound K Treatment by Inhibiting NF-κB/NLRP3 Inflammasome and Enhancing Autophagy and SIRT1Chung-Yao Wu, Kuo-Feng Hua, Wan-Han Hsu, et al.
Pageof 76